Novo Nordisk ADR (NYSE: NVO) is -2.65% lower on its value in year-to-date trading and has touched a low of $78.17 and a high of $148.15 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVO stock was last observed hovering at around $83.91 in the last trading session, with the day’s loss setting it -0.17%.
Currently trading at $83.74, the stock is -0.03% and -9.28% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.84 million and changing -0.20% at the moment leaves the stock -29.70% off its SMA200. NVO registered -29.27% loss for a year compared to 6-month loss of -37.26%. The firm has a 50-day simple moving average (SMA 50) of $92.7586 and a 200-day simple moving average (SMA200) of $119.33445.
The stock witnessed a -2.92% gain in the last 1 month and extending the period to 3 months gives it a -22.20%, and is 1.36% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.56% over the week and 2.49% over the month.
Novo Nordisk ADR (NVO) has around 76302 employees, a market worth around $281.88B and $42.09B in sales. Current P/E ratio is 25.51 and Fwd P/E is 17.85. Profit margin for the company is 34.81%. Distance from 52-week low is 7.13% and -43.48% from its 52-week high. The company has generated returns on investments over the last 12 months (45.25%).
with sales reaching $81.76B over the same period.The EPS is expected to grow by 20.42% this year, but quarterly earnings will post 21.08% year-over-year. Quarterly sales are estimated to grow 25.11% in year-over-year returns.
Novo Nordisk ADR (NVO) Top Institutional Holders
The shares outstanding are 3.37B, and float is at 3.36B with Short Float at 0.25%.
The top institutional shareholder in the company is JENNISON ASSOCIATES LLC with over 21.22 million shares valued at $3.03 billion. The investor’s holdings represent 0.4758% of the NVO Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 19.49 million shares valued at $$2.78 billion to account for 0.4371 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 14.61 million shares representing 0.3276% and valued at over $2.09 billion, while BANK OF AMERICA CORP /DE/ holds 0.3182 of the shares totaling 14.19 million with a market value of $2.03 billion.
Novo Nordisk ADR (NVO) Insider Activity
#####
